HFCAS OpenIR

浏览/检索结果: 共3条,第1-3条 帮助

已选(0)清除 条数/页:   排序方式:
Targeting KRAS mutant cancers: from druggable therapy to drug resistance 期刊论文
MOLECULAR CANCER, 2022, 卷号: 21
作者:  Zhu, Chunxiao;  Guan, Xiaoqing;  Zhang, Xinuo;  Luan, Xin;  Song, Zhengbo;  Cheng, Xiangdong;  Zhang, Weidong;  Qin, Jiang-Jiang
收藏  |  浏览/下载:36/0  |  提交时间:2022/12/23
KRAS mutations  Druggable  Resistance  Combination therapy  
JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against MYCN-amplified small cell lung cancer 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 49, 页码: 86312-86324
作者:  Wang, Huogang;  Hong, Bo;  Li, Xuemin;  Deng, Ke;  Li, Hong;  Lui, Vivian Wai Yan;  Lin, Wenchu
浏览  |  Adobe PDF(9738Kb)  |  收藏  |  浏览/下载:97/40  |  提交时间:2018/08/17
Small Cell Lung Cancer  N-myc  Bcl-2  Jq1  Abt-263  
Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology 期刊论文
BMC BIOINFORMATICS, 2016, 卷号: 17, 期号: 无, 页码: 1-12
作者:  Zhao, Zheng;  Martin, Che;  Fan, Raymond;  Bourne, Philip E.;  Xie, Lei
浏览  |  Adobe PDF(2941Kb)  |  收藏  |  浏览/下载:135/84  |  提交时间:2017/10/30
Drug Repositioning  Infectious Disease  Indinavir  Sinefungin  Binding Site Similarity  Rna-directed Rna Polymerase  Vp24